Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company's products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.
Nice patience on that one @Brendan Cowie ! I had it at 19.74 in April, but sold for a hair under 21.00. - Their generic depression drug was approved by the FDA today - Volume on the rally significantly increased from the last one and that is what buyers needed to shift price away from the auction. - Trend line break and now ready to backfill those panic candles. - Upward horizontal resistance from April 2014 at $29.12 and there is also still a virgin gap still unfilled around $33.58.
